1. Home
  2. SCHW vs ABT Comparison

SCHW vs ABT Comparison

Compare SCHW & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles Schwab Corporation (The)

SCHW

Charles Schwab Corporation (The)

HOLD

Current Price

$93.15

Market Cap

167.1B

Sector

Finance

ML Signal

HOLD

ABT

Abbott Laboratories

HOLD

Current Price

$107.97

Market Cap

189.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCHW
ABT
Founded
1971
1888
Country
United States
United States
Employees
32700
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.1B
189.6B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
SCHW
ABT
Price
$93.15
$107.97
Analyst Decision
Buy
Strong Buy
Analyst Count
16
16
Target Price
$114.25
$139.38
AVG Volume (30 Days)
9.6M
6.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.40%
2.33%
EPS Growth
N/A
N/A
EPS
N/A
3.72
Revenue
N/A
$44,328,000,000.00
Revenue This Year
$12.83
$8.92
Revenue Next Year
$8.79
$7.39
P/E Ratio
$20.51
$29.11
Revenue Growth
N/A
5.67
52 Week Low
$65.88
$105.27
52 Week High
$107.50
$137.49

Technical Indicators

Market Signals
Indicator
SCHW
ABT
Relative Strength Index (RSI) 42.07 35.98
Support Level $91.05 $105.27
Resistance Level $97.86 $113.76
Average True Range (ATR) 2.23 1.93
MACD -0.08 -0.43
Stochastic Oscillator 36.81 2.91

Price Performance

Historical Comparison
SCHW
ABT

About SCHW Charles Schwab Corporation (The)

Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.9 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of 2025. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: